Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Skin & Soft Tissues Diseases specialty page provides skin & soft tissue-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


United States Maintains Measles Elimination Status Despite Record Year
The announcement came just 1 day after health officials in New York State declared the end of the Rockland County measles outbreak.
Examining the 2018-19 New York State Measles Outbreaks
Two late breaker abstracts at IDWeek 2019 provide an in-depth analysis of the 2018-19 measles outbreaks in the state of New York.
No New Measles Cases Documented Last Week in United States
According to the CDC, there were no new cases of measles reported during the week of September 6-12, 2019.
OASIS Pooled Results: Omadacycline Safe and Efficacious in IVDU and non-IVDU
Investigators have presented the microbiological, efficacy, and safety results in the pooled intravenous drug use vs non-intravenous drug use patients in 2 phase 3 ABSSSI studies, OASIS-1 and 2.
Study Reveals Gaps in Mumps Immunity Among Vaccinated Individuals
A new study of college-aged individuals demonstrated insufficient immunity in a fraction of participants who were vaccinated against mumps in childhood.
4 European Countries Lose Measles Elimination Status
The European Regional Verification Commission for Measles and Rubella Elimination concluded that Albania, Czechia, Greece, and the United Kingdom have lost ground in the fight to eradicate measles.
Comparing Effectiveness of Agents for MSSA Bacteremia
Evidence demonstrates that antimicrobial therapy with an anti-staphylococcal β-lactam antibiotic is the gold standard for treatment of SAB caused by MSSA, but confusion about which agent—particularly cefazolin versus an anti-staphylococcal penicillin—is preferred remains an unanswered question
Essential Vaccines by Age Group
As outbreaks of vaccine-preventable diseases grow, it is important to review vaccination recommendations by age group.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?